Weekly Intelligence · 5 articles

Vet Industry Intel: May 17 – May 23, 2026

High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.

Regulatory & Policy (4) Products & Technology (1)

Regulatory & Policy

May 19, 2026 [8/10] fda_cvm

FDA approves cosyntropin injection for use in canines - DVM360

The FDA has approved cosyntropin injection for use in canines.

FDA · DVM360

May 20, 2026 [8/10] fda_cvm

FDA grants conditional approval to targeted therapy for canine Chiari-like malformation and syringomyelia - DVM360

The FDA has granted conditional approval to a targeted therapy for canine Chiari-like malformation and syringomyelia.

FDA · DVM360

May 19, 2026 [8/10] fda_cvm

FDA Approval Of Tessie Puts Orion’s Animal Health Potential In Focus - simplywall.st

The FDA has granted approval for Tessie, bringing positive attention to Orion's animal health portfolio and market potential.

FDA · Orion

May 20, 2026 [7/10] fda_cvm

Approved by FDA: Precision Fermentation Animal Protein in Pet Food - Truth about Pet Food

The FDA has approved precision fermentation animal protein for use in pet food, marking a regulatory milestone for alternative ingredients in the veterinary and pet nutrition space.

FDA

Products & Technology

May 19, 2026 [8/10] fda_cvm

Dechra Announces FDA Approval of CosACTHen® (cosyntropin injection), the First and Only Cosyntropin Approved Specifically for Canine Patients - BioSpace

Dechra announced FDA approval for CosACTHen (cosyntropin injection), making it the first and only cosyntropin approved specifically for canine patients.

Dechra · FDA · BioSpace